In addition, preliminary experiments in pancreatic cancer tissue culture cell lines demonstrate that the activin neutralizing antibody blocks activin functions as measured by a decrease in SMAD2 phosphorylation (data not shown). Here, SMAD2 is linked to familial pancreatic carcinoma.